John Vandermosten

Stock Analyst at Zacks Investment Research

(0.04)
# 4,269
Out of 4,876 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by John Vandermosten

Tiziana Life Sciences
Apr 12, 2021
Initiates: Not Rated
Price Target: $7.5
Current: $1.60
Upside: +368.75%